14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
As of Jul 28, 2026, ABNG (ABNG) is the stronger overall head-to-head candidate over ORLG (ORLG) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ORLG carries a Unified Composite Score of 46.6/100 (HOLD) at $12.32 (N/M Forward P/E, N/A operating margin), whereas ABNG carries 53.0/100 (HOLD) at $20.21 (N/M Forward P/E, N/A operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ORLG vs ABNG. Trailing 12-month operating profitability (ORLG N/A vs ABNG N/A) and valuation multiples (ORLG N/M vs ABNG N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ORLG vs ABNG Key Questions & Quantitative Answers
As of Jul 28, 2026, ABNG (ABNG) is the stronger overall head-to-head candidate over ORLG (ORLG) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ORLG carries a Unified Composite Score of 46.6/100 (HOLD) at $12.32 (N/M Forward P/E, N/A operating margin), whereas ABNG carries 53.0/100 (HOLD) at $20.21 (N/M Forward P/E, N/A operating margin). Technically, ORLG sits in a Neutral phase (RSI 56.8, UNCLASSIFIED options structure) and ABNG sits in a Markup phase (RSI 61.3, UNCLASSIFIED options structure).
ORLG and ABNG split Growth & Scale metrics: ORLG posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ABNG at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ORLG generates N/A in USD-normalized revenue versus N/A for ABNG. In operating R&D and SG&A reinvestment, ORLG deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ABNG.
ORLG and ABNG trade at balanced relative valuation multiples. ORLG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ABNG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ORLG (N/A ROE) versus ABNG (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, ORLG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.21β · 85% Vol realized risk). By comparison, ABNG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.34β · 71% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Jul 28, 2026. For educational research only; not investment advice.